Intest Res > Volume 19(1); 2021 > Article |
|
Conflict of Interest
Jeon SR is an editorial board member of the journal but did not involve in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.
Author Contribution
Conceptualization: Jeon SR. Methodology: Jeon SR. Formal analysis: Jeong Y, Jeon SR. Acquisition of data: Moon JR, Cho JH, Park JS, Park H, Lee KH, Ko BM. Visualization: Park S. Writing - original draft: Jeong Y. Writing - review and editing: Jeon SR, Kim HG, Lee TH, Jang JY, Lee JS, Kim JO. Approval of final manuscript: all authors.
Variable | UC (n = 48) |
---|---|
Age at UC diagnosis (yr) | 38.9 ± 14.8 |
Male sex | 26 (54.2) |
Previous operation history | 5 (10.4) |
Appendectomy | 1 (20.0) |
Perianal operation | 2 (40.0) |
Othersa | 2 (40.0) |
Disease extension at diagnosis at diagnosis | |
E1 (proctitis) | 18 (37.5) |
E2 (left-sided colitis) | 10 (20.8) |
E3 (pan-colitis) | 20 (41.7) |
Disease activity at diagnosis | |
Clinical remission (Mayo score 0-2) | 1 (2.1) |
Mild activity (Mayo score 3-5) | 17 (35.4) |
Moderate activity (Mayo score 6-10) | 28 (58.3) |
Severe activity (Mayo score 11-12) | 2 (4.2) |
Disease activity at NLR, PLR and FC measurement | |
Clinical remission (Mayo score 0-2) | 9 (18.8) |
Mild activity (Mayo score 3-5) | 19 (39.6) |
Moderate activity (Mayo score 6-10) | 15 (31.2) |
Severe activity (Mayo score 11-12) | 5 (10.4) |
Medication use at NLR, PLR and FC measurement | |
5-ASA | 33 (68.7) |
5-ASA+AZA | 5 (10.4) |
5-ASA+steroid | 4 (8.3) |
5-ASA+steroid+AZA | 2 (4.2) |
5-ASA+AZA+anti-TNF | 2 (4.2) |
5-ASA+anti-TNF | 2 (4.2) |
Parameter |
Control vs. UC |
Mild to moderate vs. severe |
|||
---|---|---|---|---|---|
P-valuea | Adjusted P-valueb | P-valuea | Adjusted P-valueb | ||
WBC | PLR | 0.690 | 1.000 | 0.037 | 0.560 |
NLR | 0.036 | 0.363 | 0.005 | 0.071 | |
ESR | 0.712 | 1.000 | 0.143 | 1.000 | |
CRP | 0.131 | 1.000 | 0.046 | 0.693 | |
FC | - | - | 0.122 | 1.000 | |
PLR | NLR | 0.006 | 0.059 | 0.017 | 0.165 |
ESR | 0.962 | 1.000 | 0.680 | 1.000 | |
CRP | 0.190 | 1.000 | 0.214 | 1.000 | |
FC | - | - | 0.457 | 1.000 | |
NLR | ESR | 0.061 | 0.612 | 0.045 | 0.449 |
CRP | 0.511 | 1.000 | 0.490 | 1.000 | |
FC | - | - | 0.374 | 1.000 | |
ESR | CRP | 0.181 | 1.000 | 0.260 | 1.000 |
FC | - | - | 0.714 | 1.000 | |
CRP | FC | - | - | 0.674 | 1.000 |